Cannabis and the Endocannabinoid System
The Carlat Psychiatry Report, Volume 12, Number 6, June 2014
https://www.thecarlatreport.com/newsletter-issue/tcprv12n6/
Issue Links: Learning Objectives | Editorial Information
Topics: Substance Abuse | Understanding Psychiatric Research
Tisa Adkinson, DO
Child and Adolescent and Addiction Psychiatrist, CARES, the Child and Family Institute, New York, NY
Dr. Adkinson has disclosed that she has no relevant relationships or commercial interests in any companies related to this educational activity.
Pavan Madan, MD
Child and Adolescent Psychiatry Fellow, Mount Sinai St. Luke’s-Roosevelt Hospital Center, New York, NY
Dr. Madan has disclosed that he has no relevant relationships or commercial interests in any companies related to this educational activity.
Considering the increased efforts to legalize marijuana in many states, greater public awareness of marijuana and its potential medicinal uses, and new research on cannabis and its constituents, it is essential that psychiatrists understand some of its proposed benefits—and fundamental risks.
You can't view details of this content, please login or buy subscription here